The effects of haplotypes on MCV, HbF, D50 and % DRBCs
Patient haplotype . | No. . | MCV, mean ± SD . | % HbF, mean ± SD . | α−Thal del, % . | D50, mean ± SD . | % DRBCs, mean ± SD . |
---|---|---|---|---|---|---|
Benin/Benin | 200 | 88.7 ± 9.6* | 7.4 ± 5.2* | 49*† | 1.096 ± 0.003* | 13.4 ± 7.7 |
Benin/CAR | 33 | 88.1 ± 6.7 | 7.0 ± 5.5† | 42‡ | 1.096 ± 0.003 | 14.8 ± 9.6 |
Benin/Cameroon | 24 | 83.8 ± 10.2 | 5.9 ± 3.7‡ | 42 | 1.095 ± 0.003 | 9.8 ± 7.5 |
Benin/Senegal | 31 | 88.6 ± 9.6 | 9.6 ± 6.2§ | 35§ | 1.096 ± 0.003 | 13.3 ± 7.8 |
CAR/CAR | 134 | 83.2 ± 9.9*†‡ | 5.7 ± 4.4*§‖ | 64*‡§ | 1.095 ± 0.003*† | 11.3 ± 7.4 |
Senegal/Senegal | 38 | 91.5 ± 11.1† | 11.7 ± 5.9*†‡‖¶ | 29*† | 1.097 ± 0.002† | 13.0 ± 7.2 |
Other | 40 | 89.2 ± 8.6‡ | 7.2 ± 4.7¶ | 50 | 1.096 ± 0.003 | 13.2 ± 7.8 |
Patient haplotype . | No. . | MCV, mean ± SD . | % HbF, mean ± SD . | α−Thal del, % . | D50, mean ± SD . | % DRBCs, mean ± SD . |
---|---|---|---|---|---|---|
Benin/Benin | 200 | 88.7 ± 9.6* | 7.4 ± 5.2* | 49*† | 1.096 ± 0.003* | 13.4 ± 7.7 |
Benin/CAR | 33 | 88.1 ± 6.7 | 7.0 ± 5.5† | 42‡ | 1.096 ± 0.003 | 14.8 ± 9.6 |
Benin/Cameroon | 24 | 83.8 ± 10.2 | 5.9 ± 3.7‡ | 42 | 1.095 ± 0.003 | 9.8 ± 7.5 |
Benin/Senegal | 31 | 88.6 ± 9.6 | 9.6 ± 6.2§ | 35§ | 1.096 ± 0.003 | 13.3 ± 7.8 |
CAR/CAR | 134 | 83.2 ± 9.9*†‡ | 5.7 ± 4.4*§‖ | 64*‡§ | 1.095 ± 0.003*† | 11.3 ± 7.4 |
Senegal/Senegal | 38 | 91.5 ± 11.1† | 11.7 ± 5.9*†‡‖¶ | 29*† | 1.097 ± 0.002† | 13.0 ± 7.2 |
Other | 40 | 89.2 ± 8.6‡ | 7.2 ± 4.7¶ | 50 | 1.096 ± 0.003 | 13.2 ± 7.8 |
The symbols indicate significant differences between the means sharing the same symbol. For example, the mean of MCV for SS patients with Benin/Benin haplotype is significantly different from the mean of patients with CAR/CAR haplotype. The statistical significance, defined as P < .05, was obtained with ANOVA test and Tukey adjustment for multiple comparisons, and χ2 test for α status when authorized.